Unicycive Therapeutics In... (UNCY)

AI Score

Unlock

0.64

0.00 (0.00%)

At close: Apr 25, 2025, 10:00 AM

Unicycive Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	26.14M	32.35M	41.78M	48.93M	9.7M	14.35M	18.82M	24.33M	455K	7.01M	10.57M	13.62M	16.58M	18.01M	1K	147K	n/a	63K	1K	-15K	15K	-25K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	30K	n/a	50K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	-1	n/a	n/a	-953K	-1.02M	-174K	-215K	-256K	n/a	n/a	n/a	864K	272K	n/a	n/a	n/a	-15K	n/a	-25K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	939K	687K	594K	503K	325K	682K	320K	319K	159K	69K	104K	137K	126K	1.71M	864K	272K	204K	142K	n/a	n/a	n/a	n/a
Total Current Assets	30.95M	37.74M	44.05M	51.68M	13.4M	18.57M	21.93M	26.18M	2.64M	9.96M	12.56M	15.46M	18.41M	19.78M	913K	513K	204K	219K	28K	15K	19K	25K
Property-Plant & Equipment	720K	833K	647K	709K	792K	873K	953K	1.02M	174K	215K	256K	296K	333K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	720K	833K	647K	709K	792K	873K	953K	1.02M	174K	215K	256K	296K	333K	n/a	864K	272K	n/a	n/a	n/a	-15K	n/a	-25K
Total Assets	31.67M	38.57M	44.7M	52.38M	14.19M	19.44M	22.88M	27.2M	2.82M	10.18M	12.82M	15.76M	18.74M	19.78M	913K	513K	204K	219K	28K	n/a	19K	n/a
Account Payables	966K	548K	1.47M	1.24M	821K	990K	446K	610K	892K	2.22M	747K	589K	742K	49K	357K	160K	184K	216K	427K	n/a	322K	n/a
Deferred Revenue	n/a	n/a	-360K	208K	1.00	2.53M	1.69M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	92K	542K	360K	n/a	18K	n/a	303K	276K	n/a	165K	48K	27K	29K	103K	4.12M	3.48M	2.51M	1.77M	762K	n/a	460K	n/a
Other Current Liabilities	18.94M	9.37M	7.77M	25.15M	13.12M	11.53M	12.68M	13.11M	n/a	-89K	-48K	-27K	-29K	n/a	-23K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	24.12M	10.46M	13.09M	30.28M	17.53M	15.46M	15.42M	15.97M	3.28M	5.52M	2.83M	2.4M	2.1M	785K	5.12M	3.92M	2.88M	2.08M	1.31M	n/a	903K	n/a
Long-Term Debt	n/a	n/a	n/a	46.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	117K	265K	274K	46.56M	466K	552K	634K	715K	1.05M	29K	72K	114K	155K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	24.24M	10.72M	13.36M	76.84M	18M	16.01M	16.05M	16.68M	3.28M	5.55M	2.91M	2.52M	2.26M	785K	5.12M	3.92M	2.88M	2.08M	1.31M	n/a	903K	n/a
Total Debt	773K	807K	634K	46.9M	811K	866K	937K	991K	201K	194K	280K	296K	335K	109K	4.12M	3.48M	2.51M	1.77M	762K	n/a	460K	n/a
Common Stock	114K	98K	43K	37K	35K	35K	15K	15K	15K	15K	15K	15K	15K	15K	9K	9K	9K	37K	37K	n/a	36K	n/a
Retained Earnings	-101.27M	-79.75M	-75.65M	-85.5M	-64.54M	-56.74M	-52.41M	-48.57M	-34M	-28.67M	-23.11M	-19.48M	-15.94M	-13.19M	-7.99M	-6.89M	-5.92M	-5.04M	-4.34M	n/a	-3.66M	n/a
Comprehensive Income	n/a	n/a	n/a	-46.22M	n/a	-44K	-26.2M	n/a	n/a	n/a	n/a	n/a	n/a	0.00	-0.00	n/a	n/a	n/a	n/a	-884K	n/a	-1.21M
Shareholders Equity	7.43M	27.85M	31.34M	-24.46M	-3.81M	3.43M	6.83M	10.52M	-466K	4.63M	9.91M	13.24M	16.48M	19M	-4.2M	-3.4M	-2.67M	-1.86M	-1.3M	-884K	-884K	-1.21M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	30K	n/a	50K